Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)
The purpose of this study is to evaluate the clinical and angiographic outcome of implantation of stents eluting or not eluting Sirolimus in patients with complex coronary artery lesions suitable for percutaneous coronary intervention.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Randomized Multicenter Comparison of Sirolimus Versus Bare Metal Stent Implantation in Complex Coronary Lesions. Acronym: Scand Stent|
- Minimal lumen diameter
- Frequency of restenosis (>50%) at 6 months.
- Diameter stenosis, late loss and loss index at 6 months MACE: death, myocardial infarction, target lesion revascularisation within 12 months and 24 months
|Study Start Date:||October 2002|
|Estimated Study Completion Date:||June 2006|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00151658
|Copenhagen, Denmark, DK-2100|
|Principal Investigator:||Henning Kelbaek, MD||Rigshospitalet, Denmark|